ZyVersa Therapeutics Stock (NASDAQ: ZVSA) stock price, news, charts, stock research, profile.
Open | $3.20 |
Close | $2.96 |
Volume / Avg. | 90.68K / 146.95K |
Day Range | $2.84 - $3.23 |
52 Wk Range | 2.61 - 159.60 |
Market Cap | $3.07M |
P/E Ratio | 0.00 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 5.47% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ZyVersa Therapeutics (NASDAQ:ZVSA) through any online brokerage.
Other companies in ZyVersa Therapeutics’s space includes: Alzamend Neuro (NASDAQ:ALZN), Dermata Therapeutics (NASDAQ:DRMA), Tharimmune (NASDAQ:THAR), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
ZyVersa Therapeutics has a consensus price target of $12.00.
The stock price for ZyVersa Therapeutics (NASDAQ: ZVSA) is $2.98 last updated August 23, 2024 at 6:01 PM EDT.
There are no upcoming dividends for ZyVersa Therapeutics.
ZyVersa Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for ZyVersa Therapeutics.
ZyVersa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.